Posts

Raymond James Has Strong Forecast for Hydro One Q2 Earn...

Hydro One Limited (TSE:H – Free Report) – Research analysts at Raymond James upp...

Craig Wright sent enemies to legal ‘hell,’ says judge i...

A British High Court has issued a restraining order against computer scientist C...

Crypto market liquidation tops $730 million as Bitcoin ...

Read more on https://www.fxstreet.com

Blend Labs’ (BLND) “Buy” Rating Reaffirmed at Canaccord...

Canaccord Genuity Group reiterated their buy rating on shares of Blend Labs (NYS...

Liquidia’s (LQDA) Buy Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Liquidia (NASDAQ:LQDA – F...

Ocugen (NASDAQ:OCGN) Earns Buy Rating from Chardan Capital

Chardan Capital reissued their buy rating on shares of Ocugen (NASDAQ:OCGN – Fre...

Silvaco Group (NASDAQ:SVCO) Price Target Cut to $10.00 ...

Silvaco Group (NASDAQ:SVCO – Free Report) had its price target reduced by Needha...

HC Wainwright Reaffirms Buy Rating for BitFuFu (NASDAQ:...

HC Wainwright restated their buy rating on shares of BitFuFu (NASDAQ:FUFU – Free...

Canaccord Genuity Group Reaffirms “Buy” Rating for Hut ...

Canaccord Genuity Group reaffirmed their buy rating on shares of Hut 8 (NASDAQ:H...

Diodes (NASDAQ:DIOD) Price Target Lowered to $55.00 at ...

Diodes (NASDAQ:DIOD – Free Report) had its price objective lowered by Benchmark ...

Astera Labs (NASDAQ:ALAB) Rating Increased to Overweigh...

Morgan Stanley upgraded shares of Astera Labs (NASDAQ:ALAB – Free Report) from a...

Paycor HCM (PYCR) Projected to Post Quarterly Earnings ...

Paycor HCM (NASDAQ:PYCR – Get Free Report) is expected to be releasing its Q3 20...

Needham & Company LLC Issues Pessimistic Forecast for L...

Lantronix (NASDAQ:LTRX – Free Report) had its price target reduced by Needham & ...

PAR Technology (NYSE:PAR) Earns “Buy” Rating from Needh...

Needham & Company LLC reiterated their buy rating on shares of PAR Technology (N...

Olema Pharmaceuticals (OLMA) Expected to Announce Quart...

Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) is anticipated to issue it...

Erasca (ERAS) to Release Earnings on Wednesday

Erasca (NASDAQ:ERAS – Get Free Report) is expected to issue its Q1 2025 quarterl...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.